KRT4 antibody (AA 181-292)
Quick Overview for KRT4 antibody (AA 181-292) (ABIN6939863)
Target
See all KRT4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 181-292
-
Purification
- Purified by Protein A/G
-
Immunogen
- Recombinant fragment (around aa 181-292) of human KRT4 protein (exact sequence is proprietary)
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Positive Control: HeLa, A549 or A431 cells. Skin, Cervix or Esophagus.
Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Expiry Date
- 24 months
-
-
- KRT4 (Keratin 4 (KRT4))
-
Alternative Name
- KRT4
-
Background
- Cytokeratin 4 (KRT4) is an intermediate filament protein associated with Cytokeratin 13 (KRT13). It is expressed in suprabasal cells of non-keratinized stratified squamous epithelium of esophagus, cornea, anus, larynx, pharynx and tongue. Decreased expression of KRT4 is associated with head and neck squamous carcinoma. It is helpful in differentiation of squamous cell carcinoma of esophagus origin from that of thyroid origin.
-
Molecular Weight
- 67kDa
-
Gene ID
- 3851
-
UniProt
- P19013
Target
-